Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 12

Cost-effectiveness analysis of umeclidinium/vilanterol for the management of patients with moderate to very severe COPD using an economic model

Total article views   HTML views PDF downloads Totals
7,178 Dovepress* 5,880+ 1,680 7,560
PubMed Central* 1,298 471 1,769
Totals 7,178 2,151 9,329
*Since 24 March 2017
Total mentioned Facebook Delicious Reddit Twitter Others
6 1 0 0 1 4

View citations on PubMed Central and Google Scholar